Journal article
Canadian expert consensus: optimal treatment of neovascular age-related macular degeneration
Abstract
BACKGROUND: New therapeutic approaches, particularly anti-vascular endothelial growth factor (anti-VEGF) therapies, prevent, and in some cases reverse, vision damage caused by age-related macular degeneration (AMD). Unequal access to care across Canada remains a problem for many retina specialists and their patients.
OBJECTIVE: To develop a consensus concerning the management of patients with exudative age-related macular degeneration (AMD).
Authors
Cruess AF; Berger A; Colleaux K; Greve M; Harvey P; Kertes PJ; Sheidow T; Tourville E; Williams G; Wong D
Journal
Canadian Journal of Ophthalmology, Vol. 47, No. 3, pp. 227–235
Publisher
Elsevier
Publication Date
June 2012
DOI
10.1016/j.jcjo.2012.03.007
ISSN
0008-4182